AI assistant
Sending…
RESMED INC — Director's Dealing 2014
Sep 3, 2014
30071_dirs_2014-09-03_acd697a0-b143-48d7-9296-d1cd94c349ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-08-29
Reporting Person: FARRELL PETER C (Director, Executive Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-08-29 | ResMed Common Stock | F | 4473 | $53.050 | Disposed | 481264 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 22783 | Indirect |
| ResMed Common Stock | 200000 | Indirect |
Footnotes
F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 9/1/2011.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29